C. Bryce
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Oncology top 10%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Global Cancer Incidence and Screening
Papers in
-
- Breast Cancer Treatment Studies 9
- Oncology 9
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 3
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- Ivo A. Olivotto (5 shared papers)Stephen Chia (3 shared papers)Caroline Speers (2 shared papers)Anthony W. Tolcher (4 shared papers)Jeremy S. H. Jackson (3 shared papers)Donna Mates (3 shared papers)Malcolm Hayes (1 shared paper)Joseph Ragaz (4 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Cancer (2 papers)Annals of Oncology (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)The Lancet (1 paper)
- Partner nations
- CanadaHungaryUnited Kingdom
In The Last Decade
C. Bryce
15 papers receiving 678 citations
Peers
Comparison fields: 5 of 57
- Cancer Research 407
- Oncology 413
- Pathology and Forensic Medicine 164
- Pulmonary and Respiratory Medicine 170
- Dermatology 38
Countries citing papers authored by C. Bryce
This map shows the geographic impact of C. Bryce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Bryce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Bryce more than expected).
Fields of papers citing papers by C. Bryce
This network shows the impact of papers produced by C. Bryce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Bryce. The network helps show where C. Bryce may publish in the future.
Co-authors
The 25 scholars most cited alongside C. Bryce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A phase I dose-finding study of combined treatment with an antisense Bcl-2 oligonucleotide (Genasense) and mitoxantrone in patients with metastatic hormone-refractory prostate cancer. | 2001 | 156 |
| 2 | 2004 | 116 | |
| 3 | 1998 | 108 | |
| 4 | 2000 | 93 | |
| 5 | 2006 | 78 | |
| 6 | 1999 | 75 | |
| 7 | 1996 | 54 | |
| 8 | 1998 | 9 | |
| 9 | 2005 | 7 | |
| 10 | 1998 | 3 | |
| 11 | 2009 | 3 | |
| 12 | 1998 | 2 | |
| 13 | 2002 | 1 | |
| 14 | 2002 | 1 | |
| 15 | 2009 | 1 |
About C. Bryce
C. Bryce is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Surgery and Molecular Biology, having authored 15 papers that have together received 707 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (9 papers), Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (3 papers), Advanced Breast Cancer Therapies (2 papers), Estrogen and related hormone effects (2 papers), Breast Lesions and Carcinomas (2 papers), Inflammatory mediators and NSAID effects (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Cancer Research (407 citations), Oncology (413 citations), Pathology and Forensic Medicine (164 citations), Pulmonary and Respiratory Medicine (170 citations) and Dermatology (38 citations). C. Bryce has collaborated with scholars based in Canada, Hungary and United Kingdom. Frequent co-authors include Ivo A. Olivotto, Stephen Chia, Caroline Speers, Anthony W. Tolcher, Jeremy S. H. Jackson, Donna Mates, Malcolm Hayes, Joseph Ragaz, Martin Gleave and Nicholas Murray. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Annals of Oncology, International Journal of Radiation Oncology*Biology*Physics and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.